These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

514 related items for PubMed ID: 7828614

  • 1. HMPAO SPET and FDG PET in Alzheimer's disease and vascular dementia: comparison of perfusion and metabolic pattern.
    Mielke R, Pietrzyk U, Jacobs A, Fink GR, Ichimiya A, Kessler J, Herholz K, Heiss WD.
    Eur J Nucl Med; 1994 Oct; 21(10):1052-60. PubMed ID: 7828614
    [Abstract] [Full Text] [Related]

  • 2. Regional cerebral blood flow single-photon emission tomography with 99mTc-HMPAO and the acetazolamide test in the evaluation of vascular and Alzheimer's dementia.
    Pávics L, Grünwald F, Reichmann K, Horn R, Kitschenberg A, Hartmann A, Menzel C, Schomburg AG, Overbeck B, Csernay L, Biersack HJ.
    Eur J Nucl Med; 1999 Mar; 26(3):239-45. PubMed ID: 10079314
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Assessment of cerebral perfusion with single-photon emission tomography in normal subjects and in patients with Alzheimer's disease: effects of region of interest selection.
    Claus JJ, van Harskamp F, Breteler MM, Krenning EP, van der Cammen TJ, Hofman A, Hasan D.
    Eur J Nucl Med; 1994 Oct; 21(10):1044-51. PubMed ID: 7828613
    [Abstract] [Full Text] [Related]

  • 5. Brain perfusion scintigraphy with 99mTc-HMPAO or 99mTc-ECD and 123I-beta-CIT single-photon emission tomography in dementia of the Alzheimer-type and diffuse Lewy body disease.
    Donnemiller E, Heilmann J, Wenning GK, Berger W, Decristoforo C, Moncayo R, Poewe W, Ransmayr G.
    Eur J Nucl Med; 1997 Mar; 24(3):320-5. PubMed ID: 9143472
    [Abstract] [Full Text] [Related]

  • 6. [Molecular neuroimaging in the study of cognitive impairment: contribution of the cerebral blood flow SPECT with 99mTc-HMPAO and 18F-FDG PET/CT scan].
    Banzo I, Quirce R, Martínez-Rodríguez I, Jiménez-Bonilla J, Portilla-Quattrociocchi H, Medina-Quiroz P, Ortega F, Rodríguez E, Mateo I, Vázquez-Higuera JL, de Arcocha M, Carril JM.
    Rev Esp Med Nucl; 2011 Mar; 30(5):301-6. PubMed ID: 21640440
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Positron emission tomography for diagnosis of Alzheimer's disease and vascular dementia.
    Mielke R, Heiss WD.
    J Neural Transm Suppl; 1998 Mar; 53():237-50. PubMed ID: 9700661
    [Abstract] [Full Text] [Related]

  • 9. A comparison of (99m)Tc-HMPAO SPET changes in dementia with Lewy bodies and Alzheimer's disease using statistical parametric mapping.
    Colloby SJ, Fenwick JD, Williams ED, Paling SM, Lobotesis K, Ballard C, McKeith I, O'Brien JT.
    Eur J Nucl Med Mol Imaging; 2002 May; 29(5):615-22. PubMed ID: 11976799
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. High-resolution technetium-99m-HMPAO SPECT in patients with probable Alzheimer's disease: comparison with fluorine-18-FDG PET.
    Messa C, Perani D, Lucignani G, Zenorini A, Zito F, Rizzo G, Grassi F, Del Sole A, Franceschi M, Gilardi MC.
    J Nucl Med; 1994 Feb; 35(2):210-6. PubMed ID: 8294987
    [Abstract] [Full Text] [Related]

  • 12. Functional neuroimaging in Alzheimer's disease: how far should we go?
    Kerwin R.
    Eur J Nucl Med; 1994 Oct; 21(10):1041-3. PubMed ID: 7828612
    [No Abstract] [Full Text] [Related]

  • 13. Comparison of technetium-99m-HMPAO and technetium-99m-ECD cerebral SPECT images in Alzheimer's disease.
    van Dyck CH, Lin CH, Smith EO, Wisniewski G, Cellar J, Robinson R, Narayan M, Bennett A, Delaney RC, Bronen RA, Hoffer PB.
    J Nucl Med; 1996 Nov; 37(11):1749-55. PubMed ID: 8917168
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. A multi-institutional study of interobserver agreement in the evaluation of dementia with rCBF/SPET technetium-99m exametazime (HMPAO).
    Hellman RS, Tikofsky RS, Van Heertum R, Coade G, Carretta R, Hoffmann RG.
    Eur J Nucl Med; 1994 Apr; 21(4):306-13. PubMed ID: 8005154
    [Abstract] [Full Text] [Related]

  • 16. Regional differences between 99mTc-ECD and 99mTc-HMPAO SPET in perfusion changes with age and gender in healthy adults.
    Inoue K, Nakagawa M, Goto R, Kinomura S, Sato T, Sato K, Fukuda H.
    Eur J Nucl Med Mol Imaging; 2003 Nov; 30(11):1489-97. PubMed ID: 14579088
    [Abstract] [Full Text] [Related]

  • 17. Memory functions and rCBF (99m)Tc-HMPAO SPET: developing diagnostics in Alzheimer's disease.
    Elgh E, Sundström T, Näsman B, Ahlström R, Nyberg L.
    Eur J Nucl Med Mol Imaging; 2002 Sep; 29(9):1140-8. PubMed ID: 12192558
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Vascular dementia of Binswanger's type: clinical, neuroradiological and 99mTc-HMPAO SPET study.
    Shyu WC, Lin JC, Shen CC, Hsu YD, Lee CC, Shiah IS, Tsao WL.
    Eur J Nucl Med; 1996 Oct; 23(10):1338-44. PubMed ID: 8781138
    [Abstract] [Full Text] [Related]

  • 20. Quantitative topographical EEG compared to FDG PET for classification of vascular and degenerative dementia.
    Szelies B, Mielke R, Herholz K, Heiss WD.
    Electroencephalogr Clin Neurophysiol; 1994 Aug; 91(2):131-9. PubMed ID: 7519142
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.